HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling.

Abstract
The liver is known to be a classical immunoprivileged site with a relatively high resistance against immune responses. Here we demonstrate that highly activated liver-specific effector CD8+ T cells alone were not sufficient to trigger immune destruction of the liver in mice. Only additional innate immune signals orchestrated by TLR3 provoked liver damage. While TLR3 activation did not directly alter liver-specific CD8+ T cell function, it induced IFN-alpha and TNF-alpha release. These cytokines generated expression of the chemokine CXCL9 in the liver, thereby enhancing CD8+ T cell infiltration and liver disease in mice. Thus, nonspecific activation of innate immunity can drastically enhance susceptibility to immune destruction of a solid organ.
AuthorsKarl S Lang, Panco Georgiev, Mike Recher, Alexander A Navarini, Andreas Bergthaler, Mathias Heikenwalder, Nicola L Harris, Tobias Junt, Bernhard Odermatt, Pierre-Alain Clavien, Hanspeter Pircher, Shizuo Akira, Hans Hengartner, Rolf M Zinkernagel
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 116 Issue 9 Pg. 2456-63 (Sep 2006) ISSN: 0021-9738 [Print] United States
PMID16955143 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Interferon-alpha
  • MYD88 protein, human
  • Myd88 protein, mouse
  • Myeloid Differentiation Factor 88
  • Receptors, Tumor Necrosis Factor
  • Receptors, Tumor Necrosis Factor, Type I
  • Toll-Like Receptor 3
  • Tumor Necrosis Factor Decoy Receptors
  • Tumor Necrosis Factor-alpha
  • recombinant human tumor necrosis factor-binding protein-1
Topics
  • Adaptor Proteins, Signal Transducing (deficiency, genetics)
  • Adoptive Transfer
  • Animals
  • CD8-Positive T-Lymphocytes (immunology)
  • Cytotoxicity, Immunologic
  • Humans
  • Interferon-alpha (biosynthesis)
  • L Cells
  • Liver (immunology)
  • Liver Diseases (immunology)
  • Mice
  • Mice, Knockout
  • Myeloid Differentiation Factor 88
  • Receptors, Tumor Necrosis Factor (deficiency, genetics)
  • Receptors, Tumor Necrosis Factor, Type I
  • Toll-Like Receptor 3 (immunology)
  • Tumor Necrosis Factor Decoy Receptors
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: